Phibro Animal Health | PAHC - Cost Of Sales


Phibro Animal Health reported $207.39M in Cost of Sales for its fiscal quarter ending in December of 2024.





Cost Of Sales Change Date
Align Technology USD 363.97M 7.48M Dec/2025
ANI Pharmaceuticals USD 122.88M 6.86M Dec/2025
Assertio Holdings USD 8.89M 2.29M Jun/2024
Aurora Cannabis CAD 58.08M 11.99M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 44.78M 9.32M Sep/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Henry Schein USD 2.44B 62M Dec/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Merck USD 3.32B 531M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Pacira USD 54.62M 6.02M Dec/2025
Phibro Animal Health USD 207.39M 30.45M Dec/2024
Prestige Brands USD 131.22M 3.52M Dec/2025
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025
Zoetis USD 743M 60M Dec/2025